Edition:
United States

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

8.98USD
14 Dec 2017
Change (% chg)

$-0.10 (-1.10%)
Prev Close
$9.08
Open
$9.05
Day's High
$9.45
Day's Low
$8.92
Volume
86,359
Avg. Vol
81,472
52-wk High
$24.35
52-wk Low
$6.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.523
Mar '17 1.10 -0.492
FY 2016 Dec '16 0.32 -0.200
Sep '16 0.00 -0.649
Jun '16 0.00 -0.608
Mar '16 0.00 -0.542
FY 2015 Dec '15 0.00 -0.524
Sep '15 0.00 -0.426
Jun '15 0.32 -0.322
Mar '15 0.00 -0.254
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-17 6 1.10 1.10 1.10 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 14.93
Earnings (per share)
Quarter Ending Dec-17 6 -0.57 -0.55 -0.60 -0.90
Quarter Ending Mar-18 4 -0.62 -0.46 -0.88 -0.65
Year Ending Dec-17 6 -2.12 -2.10 -2.14 -3.13
Year Ending Dec-18 6 -2.81 -2.24 -3.69 -4.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta -- 0.92 0.91
Price to Sales (TTM) 166.72 3.92 5.95
Price to Book (MRQ) 3.01 4.85 5.68
Price to Tangible Book (MRQ) 3.01 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 76.10 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 5.15 5.62
Sales - 5 Yr. Growth Rate -- 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.90 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 25.05 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate -- 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 9.00 3.50 3.56
LT Debt to Equity (MRQ) 0.01 11.01 13.38
Total Debt to Equity (MRQ) 0.12 17.15 19.38
Interest Coverage (TTM) -- 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -3,436.95 -- --
EBITD - 5 Yr. Avg -- 18.50 15.63
Operating Margin (TTM) -3,540.97 14.76 6.56
Operating Margin - 5 Yr. Avg. -- 14.33 11.00
Pre-Tax Margin (TTM) -3,503.03 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -- 14.64 11.41
Net Profit Margin (TTM) -3,503.03 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -- 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,782 945,342,213 851,801,741
Net Income/Employee (TTM) -903,145 110,573,246 99,542,701
Receivable Turnover (TTM) -- 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.01 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.54 11.86 11.31
Return on Assets - 5 Yr. Avg. -- 12.86 12.28
Return on Investment (TTM) -57.93 15.06 14.43
Return on Investment - 5 Yr. Avg. -- 16.81 16.07
Return on Equity (TTM) -58.66 16.55 16.01
Return on Equity - 5 Yr. Avg. -- 17.82 17.27
  1 Year 3 Year 5 Year
Sales % 0.00 -- --
EPS (TTM) % -165.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Syros Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -27.21 -29.84 3 49
13 Week -44.13 -47.79 3 16
26 Week -48.86 -53.50 4 31
52 Week -39.62 -48.96 10 25
YTD -26.07 -38.14 16 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.11%
# of Holders: 95
Total Shares Held: 20,014,892
3 Mo. Net Change: -376,390
# New Positions: 25
# Closed Positions: 7
# Increased Positions: 58
# Reduced Positions: 21
# Net Buyers: 37
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.